Related Experiment Video
Updated: Aug 17, 2026

Coculture Assays to Study Macrophage and Microglia Stimulation of Glioblastoma Invasion
Published on: October 20, 2016
Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type
Wen Yin1, Yirui Kuang2, Zhaoqi Xin2
1Department of Neurosurgery, Xiangya Hospital, Central South University; Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China; Cancer Research Institute, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China; The NHC Key Laboratory of Carcinogenesis and The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, Hunan, China.
Abstract:
Apolipoprotein B mRNA-editing enzyme catalytic subunit 3C (APOBEC3C) is a member of the cytidine deaminase gene family. The function of APOBEC3C in pan-cancer and its capacity as a prognostic biomarker in gliomas remains unclear. A systematic bioinformatics analysis was used to examine the function of APOBEC3C in pan-cancer. The results showed that high APOBEC3C expression correlated with a poor prognosis and could serve as an independent prognostic indicator in gliomas. Furthermore, the correlations between APOBEC3C expression and immune infiltration, genomic instability, and epigenetic modifications were assessed. Next, we conducted experiments in vitro to further explore the function of APOBEC3C in gliomas. APOBEC3C was expressed in both the cytoplasm and nucleus. APOBEC3C promoted the proliferation, migration, and invasion of glioma cells. Moreover, APOBEC3C may promote M2-type macrophage polarization in glioma cells. Additionally, APOBEC3C may prevent R-loop accumulation modulating genomic instability in glioma cells. In summary, APOBEC3C, as an oncogene, could serve as a novel biomarker for the prognosis of glioma patients and may promote M2-type macrophage polarization and prevent R-loop accumulation in gliomas.

